Menopausal Hormone Therapy in Gynecologic Cancer Survivors: A Review of the Evidence and Practice Recommendations

Ekta Kapoor, Daniel Benrubi, Stephanie S. Faubion

Research output: Contribution to journalReview article

Abstract

Gynecologic cancers are common in the United States and represent a significant health burden. Treatment of these cancers often causes premature cessation of ovarian function, with resultant symptoms that are often more severe than those associated with natural menopause. Hormone therapy is the most effective treatment for menopausal symptoms, but the decision-making process about its use can be complex for survivors of gynecologic cancer. In this review, we provide evidence-based recommendations about the use of hormone therapy after gynecologic cancer.

Original languageEnglish (US)
Pages (from-to)488-495
Number of pages8
JournalClinical Obstetrics and Gynecology
Volume61
Issue number3
DOIs
StatePublished - Sep 1 2018

Fingerprint

Hormones
Neoplasms
Therapeutics
Menopause
Decision Making
Health

Keywords

  • endometrial cancer
  • gynecologic cancer
  • hormone therapy
  • menopause
  • ovarian cancer

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Menopausal Hormone Therapy in Gynecologic Cancer Survivors : A Review of the Evidence and Practice Recommendations. / Kapoor, Ekta; Benrubi, Daniel; Faubion, Stephanie S.

In: Clinical Obstetrics and Gynecology, Vol. 61, No. 3, 01.09.2018, p. 488-495.

Research output: Contribution to journalReview article

@article{db3a5f9c93f54dc8b5252da7cab46bcc,
title = "Menopausal Hormone Therapy in Gynecologic Cancer Survivors: A Review of the Evidence and Practice Recommendations",
abstract = "Gynecologic cancers are common in the United States and represent a significant health burden. Treatment of these cancers often causes premature cessation of ovarian function, with resultant symptoms that are often more severe than those associated with natural menopause. Hormone therapy is the most effective treatment for menopausal symptoms, but the decision-making process about its use can be complex for survivors of gynecologic cancer. In this review, we provide evidence-based recommendations about the use of hormone therapy after gynecologic cancer.",
keywords = "endometrial cancer, gynecologic cancer, hormone therapy, menopause, ovarian cancer",
author = "Ekta Kapoor and Daniel Benrubi and Faubion, {Stephanie S.}",
year = "2018",
month = "9",
day = "1",
doi = "10.1097/GRF.0000000000000381",
language = "English (US)",
volume = "61",
pages = "488--495",
journal = "Clinical Obstetrics and Gynecology",
issn = "0009-9201",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Menopausal Hormone Therapy in Gynecologic Cancer Survivors

T2 - A Review of the Evidence and Practice Recommendations

AU - Kapoor, Ekta

AU - Benrubi, Daniel

AU - Faubion, Stephanie S.

PY - 2018/9/1

Y1 - 2018/9/1

N2 - Gynecologic cancers are common in the United States and represent a significant health burden. Treatment of these cancers often causes premature cessation of ovarian function, with resultant symptoms that are often more severe than those associated with natural menopause. Hormone therapy is the most effective treatment for menopausal symptoms, but the decision-making process about its use can be complex for survivors of gynecologic cancer. In this review, we provide evidence-based recommendations about the use of hormone therapy after gynecologic cancer.

AB - Gynecologic cancers are common in the United States and represent a significant health burden. Treatment of these cancers often causes premature cessation of ovarian function, with resultant symptoms that are often more severe than those associated with natural menopause. Hormone therapy is the most effective treatment for menopausal symptoms, but the decision-making process about its use can be complex for survivors of gynecologic cancer. In this review, we provide evidence-based recommendations about the use of hormone therapy after gynecologic cancer.

KW - endometrial cancer

KW - gynecologic cancer

KW - hormone therapy

KW - menopause

KW - ovarian cancer

UR - http://www.scopus.com/inward/record.url?scp=85050979382&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050979382&partnerID=8YFLogxK

U2 - 10.1097/GRF.0000000000000381

DO - 10.1097/GRF.0000000000000381

M3 - Review article

C2 - 29762148

AN - SCOPUS:85050979382

VL - 61

SP - 488

EP - 495

JO - Clinical Obstetrics and Gynecology

JF - Clinical Obstetrics and Gynecology

SN - 0009-9201

IS - 3

ER -